Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic. (Q46135700)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Nadezda Koleganova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Eberhard Ritz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Raffi Bekeredjian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Peter Schirmacher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Claus Peter Schmitt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Marie-Luise Gross

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

2 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

520-530

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19188910%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2009.7

20 January 2020

exact match

0 references

cites work

Coronary heart disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Morphology of the heart and arteries in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Cardiac remodelling in experimental renal failure - an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Survival following parathyroidectomy among United States dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Fatty acid oxidation in the myocardium: effects of parathyroid hormone and CRF.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Effect of parathyroid hormone on myocardial energy metabolism in the rat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Intercapillary distances and capillary reserve in right and left ventricles: significance for control of tissue po2

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

1 reference

7 January 2021

Mitogen-activated protein kinases in heart development and diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Calcium-sensing receptor-mediated ERK1/2 activation requires Galphai2 coupling and dynamin-independent receptor internalization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Controversies in ventricular remodelling

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

The calcium-sensing receptor (CaR) and its disorders.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021

Expression and function of the calcium-sensing receptor in juxtaglomerular cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.7

7 January 2021